AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM - STOP ANTICOAGULANT TREATMENT AFTER 4 TO 6 WEEKS IN PATIENTS WITH REVERSIBLE RISK-FACTORS

被引：8

作者：

CHESTERMAN, CN ^{[1
]}

机构：

[1] UNIV NEW S WALES,SYDNEY,NSW 2031,AUSTRALIA

来源：

BRITISH MEDICAL JOURNAL | 1995年 / 311卷 / 7007期

关键词：

D O I：

10.1136/bmj.311.7007.700

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：700 / 701

页数：2

共 9 条

[1]

COGO A, 1995, THESIS U AMSTERDAM A, P208

[2]

COON WW, 1973, SURGERY, V73, P823

[3]

DAHLBACK B, 1995, THROMB HAEMOSTASIS, V73, P739

[4] ANTICOAGULANTS IN VENOUS THROMBOEMBOLISM [J].

FENNERTY, A ;

CAMPBELL, IA ;

ROUTLEDGE, PA .

BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6659) :1285-1288

[5]

GALLUS A, 1986, LANCET, V2, P1293

[6] THE OPTIMAL DURATION OF ANTICOAGULANT-THERAPY FOR VENOUS THROMBOSIS [J].

HIRSH, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (25) :1710-1711

[7] CLINICAL ANALYSIS OF 125 PATIENTS WITH THE LUPUS ANTICOAGULANT [J].

MORGAN, M ;

DOWNS, K ;

CHESTERMAN, CN ;

BIGGS, JC .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (02) :151-156

[8]

Research Committee of the British Thoracic Society, 1992, LANCET, V340, P873

[9] A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM [J].

SCHULMAN, S ;

RHEDIN, AS ;

LINDMARKER, P ;

CARLSSON, A ;

LARFARS, G ;

NICOL, P ;

LOOGNA, E ;

SVENSSON, E ;

LJUNGBERG, B ;

WALTER, H ;

VIERING, S ;

NORDLANDER, S ;

LEIJD, B ;

JONSSON, KA ;

HJORTH, M ;

LINDER, O ;

BOBERG, J ;

GUSTAFSSON, C ;

GRONDAHL, A ;

TORNEBOHM, E ;

JOHANSSON, M ;

LOCKNER, D ;

JOHNSSON, H ;

KOBOSKO, J ;

MALMROS, B ;

ARCINI, N ;

SAAW, J ;

STIG, R ;

WILHELMSSON, S ;

OHLSSON, A ;

MALMQVIST, K ;

ALKHALILI, F ;

PETRESCU, A ;

BROHULT, J ;

HULTING, J ;

EKLUND, SG ;

DAHLIN, L ;

MARJANOVICS, B ;

MALM, C ;

LINDGREN, A ;

FAGRELL, B ;

KALLNER, M ;

GRANQVIST, S ;

WIMAN, B ;

EGBERG, N ;

WADMAN, B ;

SNYDER, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (25) :1661-1665

← 1 →